Physicians Laboratory Online Bill Pay Online Insurance Submission

Phone (605) 322-7200

About Us
What's New at PL
Client Alerts
Career Opportunities
Medical Websites
Physicians Laboratory announces new Trichomonas testing
Untreated TV has been linked to several other condidtions, including:
  • prolonged HPV infection
  • Concurrent STIs such as Chlamydia and Gonorrhea
  • Preterm delivery
Providers will continue to receive one integrated report with all testing results.  We have updated our requisition with the option to order Trichomonas testing.  In addition, we have clarified and simplified our HPV ordering choices.

Please see the Trichomonas tab under Pathology/Cytology for more information.
HPV Co-Testing vs. HPV Only Testing

Click on the link below to read about the Quest study which concluded that screening with HPV alone misses more cervical cancer. 

Pap plus HPV

Physicians Laboratory pathologists' position regarding this co-testing and HPV alone is described in the following position paper.

Position Paper

Updated Products of Conception Guidelines

If the autopsy is requested by the parents a "Consent for Autopsy" form must be completed with the funeral home name and number designated.  If the autopsy is requested by the physician a "Request for Autopsy" form must be completed along with the funeral home designation.  If chromosome analysis alone is desired (no autopsy) place the appropriate tissue (see Fetal Chromosome Analysis procedure) in basal transport media and send to Physicians Lab.  A gross only exam will be performed and the specimen will be forwarded to the appropriate reference lab.

All forms may be found in the Referral Guide on the so-named tab on this website.  Please print the new pages for your reference.  They are attached here. 

Products of Conception Guidelines

Consent for Autopsy form

 Request for Autopsy Form

Updated Her2 Guidelines

Physicians Laboratory has updated its Her2 fixation time guidelines to reflect current literature recommendations.  Maximum fixation time has been changed from 48 to 72 hours, which is now the same as estrogen and progesterone fixation times.  Click on the link below to download the updated guidelines for your PL Referral Guide.

Updated Referral Guide page

Presentation on C. diff.

Dr. Karla Murphy has written a presentation entitled "Clostridium difficle: New Challenges from an Established Pathogen". Please click on the link below to access the presentation. 

C.diff Presentation
New Cytology Screening Guidelines Released
These new guidelines were recently published in the American Journal of Clinical Pathology by the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology.  They are in turn supported by the American College of Obstetricians and Gynecologists.
What follows is a brief synopsis of the guidelines.  We will include a link to the full article on our website under Client Alerts. 
Keep in mind that these are screening guidelines only.  For management of abnormal screening results follow ASCCP guidelines.  These are also provided on our website.

New Screening Guidelines:
• Females under the age of 21 should not be screened
• Women ages 21-29 should be screened with cytology alone every 3 years.  HPV testing is NOT recommended unless for the triage of ASC-US results.
• Women ages 30-65 years should be screened with cytology and HPV testing (co-testing) every 5 years (preferred) or cytology alone every 3 years (acceptable).  Screening intervals should not be changed for either modality based on the number of previous negative screening results.
• Women over 65 years of age with evidence of adequate negative prior screening and no history of CIN2 or more severe diagnosis within the last 20 years should not be screened
• Women with a history of CIN2 or a more severe diagnosis should be screened routinely for at least 20 years post regression or appropriate management
• Women post-hysterectomy with removal of the cervix for benign reasons may discontinue screening
• Women who have had an HPV vaccination should be screened according to the age-specific recommendations for the general population

Also, it is not recommended to perform HPV testing for a cytology diagnosis of LSIL or more severe as the HPV adds cost and does not change management.

We will be removing the “Perform HPV testing if ASC-US or LGSIL” option from our requisitions.  In addition, we will add an option for co-testing.  As before, the option to reflex to 16/18 types will be available.

In regards to insurance paying for co-testing, we can only recommend that providers and patients check with their plans to determine coverage.  There are many different plan options and patient history combinations available making it difficult to predict what testing options may be covered.
We appreciate your business and are happy to answer any questions you may have